Characterization of Lactobacillus isolated from dairy samples for probiotic properties

Anaerobe
Ashwani Kumar, Dinesh Kumar

Abstract

In the present study twelve Lactobacillus isolates (LBS 1-LBS 12) were characterized for probiotic properties. Out of the twelve, eight isolates (LBS 1-6, 8 and 11) were bile resistant (survival > 50% at 0.3% bile salt w/v) and five isolates (LBS 1, 2, 5, 6 and 11) were found acid pH value resistant (survival > 50% at pH 3). All twelve isolates inhibited the growth of Staphylococcus aureus whereas isolate LBS 2 also inhibited the growth of Escherichia coli and Salmonella typhimurium. Antibiotic susceptibility testing of isolates was also performed and isolate LBS 2 was selected for further study based on its broad spectrum effect in clinical pathogen inhibition. LBS 2 was characterized phenotypically at Institute of Microbial Technology (IMTECH), Chandigarh, India and was confirmed as Lactobacillus rhamnosus by 16S rDNA sequencing and subsequent analysis using BLAST. The gene sequence was deposited in GenBank with accession number KJ562858. Scanning electron microscopy (SEM) study was used to study in vitro epithelial cell adherence and bile salt effect on isolate LBS 2. Epithelial cells adherence assay showed positive results and surface roughness of LBS 2 increased with increase in bile salt (0.15-0.45% w/v).

References

Oct 1, 1983·The Journal of Applied Bacteriology·A Mäyrä-MäkinenH Gyllenberg
Aug 15, 1998·International Journal of Food Microbiology·G KleinG Reuter
Jan 28, 2003·Critical Reviews in Microbiology·Frank J CarrNino Maida
Jul 13, 2004·Journal of Applied Microbiology·M GarrigaM Hugas
Feb 1, 2005·International Journal of Food Microbiology·J S ZhouH S Gill
Nov 18, 2005·International Journal of Food Microbiology·Shalini Mathur, Rameshwar Singh
Mar 24, 2006·Molecular Microbiology·Erwin G ZoetendalWillem M de Vos
Nov 24, 2006·Applied and Environmental Microbiology·Anja S HummelCharles M A P Franz

❮ Previous
Next ❯

Citations

May 7, 2020·Current Microbiology·Haydee Eliza Romero-LunaGloria Dávila-Ortiz
Aug 28, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Maged S Bin MasalamRashad R Al-Hindi
Apr 1, 2019·Probiotics and Antimicrobial Proteins·Houssam AbouloifaAbdeslam Asehraou
Aug 8, 2020·Insects·Farah Nadiah RosliHamidun Bunawan
May 4, 2021·Comprehensive Reviews in Food Science and Food Safety·Jie GaoYaxin Sang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.